Search results for "Domo"

showing 10 items of 508 documents

Acinetobacter baumannii un Pseudomonas aeruginosa antibakteriālās rezistences noteikšana, lietojot fenotipiskās un molekulāri bioloģiskās metodes

2020

Acinetobacter baumannii un Pseudomonas aeruginosa ir gan Latvijā, gan visā Eiropā bieži sastopami intrahospitāli patogēni, pret kuriem antibiotiku rezistence pieaug ik gadu. Visbiežāk tie skar imūnsupresētus cilvēkus, apdraudot veselību un dzīvību. Darba mērķis: Noteikt A.baumannii un P. aeruginosa jutību pret antibakteriālajiem līdzekļiem 2019. gadā un salīdzināt rezistences izmaiņas ar 2017. gadu, kā arī ar molekulāri bioloģisko metodi identificēt baktēriju sugas. Uzdevumi: 1.No elpceļu paraugiem ar BBL CrystalTM identifikācijas sistēmām identificēt izolātus. 2. Noteikt antimikrobiālo jutību, izmantojot Bauer-KirbyTM disku difūzijas testu un MIC, lietojot ETM-testu. 3. Tipēt izdalīto bakt…

Acinetobacter baumanniibaktēriju rezistencePseudomonas aeruginosaantibakteriālie līdzekļiMedicīna
researchProduct

Risk factors for cystic fibrosis arthropathy: Data from the German cystic fibrosis registry

2021

Epidemiology and potential risk factors for cystic fibrosis arthropathy (CFA) were studied in a relevant cystic fibrosis (CF) patient cohort.Cohort study of patients included in the German CF registry in 2016-2017. Descriptive analysis, exploratory tests and multivariable logistic regression were used to assess prevalence of CFA and associated potential risk factors for adult patients with/without chronic Pseudomonas aeruginosa infection.6069 CF patients aged from 0 to 78 years were analysed. CFA was observed in 4.9% of the patients. Prevalence was significantly higher in adult patients (8.4%) compared to patients18 years (0.7%; p0.0001). Logistic regression analyses in adult patients (n=33…

AdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyAdolescentCystic FibrosisCystic fibrosis-related diabetesmedicine.disease_causeLogistic regressionCystic fibrosisDiabetes ComplicationsSex FactorsRisk FactorsGermanyInternal medicineArthropathyEpidemiologyPrevalencemedicineHumansPseudomonas InfectionsRegistriesSinusitisChildAgedPseudomonas aeruginosabusiness.industryAge FactorsInfant NewbornInfantMiddle Agedmedicine.diseaseChild PreschoolPediatrics Perinatology and Child HealthCohortExocrine Pancreatic InsufficiencyFemaleJoint DiseasesbusinessCohort studyJournal of Cystic Fibrosis
researchProduct

Spreading of sudomotor axon reflexes in human skin.

2005

Acetylcholine (ACh) activates both sudomotor fibers and primary afferent nociceptors. This leads to sudomotor and vasodilator axon reflexes, which can be diminished, for example, in neuropathies. In some neuropathies, however, there is increased axon reflex sweating, a response pattern that has never been observed for vasodilator flares.To compare both types of axon reflexes and to elucidate possible differences.In healthy young male subjects, sweat response and flare reaction in response to ACh were quantified. Constant-current iontophoresis (300 mC) of ACh was performed on the lateral lower legs. The sudomotor axon reflex was visualized with iodine starch staining, and the sweat response …

AdultMaleSensory Receptor CellsHuman skinSweatingEfferent PathwaysSympathetic Fibers PostganglionicReflexMedicineHumansPeripheral NervesAxonSkinAfferent PathwaysNerve Fibers Unmyelinatedintegumentary systemIontophoresisbusiness.industryNociceptorsAnatomyAcetylcholineSweat GlandsSudomotorVasodilationVasomotor Systemmedicine.anatomical_structurenervous systemReflexNociceptorBlood VesselsAxon reflexNeurology (clinical)businessAcetylcholinemedicine.drugNeurology
researchProduct

Somatotopic arrangement of sudomotor axon reflex sweating in humans

2005

Impaired sweating may be one of the first symptoms in neuropathies, and therefore the evaluation of sweating might facilitate their early detection. Sudomotor axon reflexes can be quantified by two different methods: quantitative sudomotor axon reflex testing (QSART) measures the amount of local sweating, whereas staining with the iodine starch reaction assesses the extension of the sudomotor axon reflex area. The aim of our study was to compare both tests at three different sites on the leg: foot, lower leg and thigh.QSART and iodine starch staining after iontophoretic stimulation with acetylcholine were performed on 15 male volunteers (mean age: 25; range 24-27 years) on the left resp. th…

AdultMaleSweatingSWEATCellular and Molecular NeuroscienceNerve FibersSweat glandReflexmedicineHumansAxonLegintegumentary systemFootEndocrine and Autonomic Systemsbusiness.industryStarchAnatomySomatotopic arrangementIontophoresisAcetylcholineSweat GlandsSudomotorAutonomic nervous systemmedicine.anatomical_structureThighReflexFemaleAxon reflexNeurology (clinical)businessIodineAutonomic Neuroscience
researchProduct

Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.

2004

Abstract Background Botulinum toxin type A (BoNT/A) is 20–50 times more effective than Botulinum toxin type B (BoNT/B) concerning the treatment of muscular hypercontractions [Sloop, R.R., Cole, B.A., Escutin, R.O., 1997. Human response to botulinum toxin injection: type B compared with type A. Neurology 49, 189–194]. Botulinum toxins block motor nerves as well as autonomic fibres [Rand, M.J., Whaler, B.C., 1965. Impairment of sympathetic transmission by botulinum toxin. Nature 206, 588–591]. Objective Purpose of this study was to analyse the dose dependent reduction of sweating using the BoNT/A preparation Botox® and to compare the results with our earlier results analysing Dysport® [Braune…

AdultMalemedicine.medical_specialtyBotulinum ToxinsTime FactorsInjections SubcutaneousSweatingBotulinum toxin aCellular and Molecular NeuroscienceMedicineHumansBotulinum toxin type BAnhidrosisBotulinum Toxins Type AHypohidrosisDose-Response Relationship DrugEndocrine and Autonomic Systemsbusiness.industryStarchBotulinum toxinSurgerySudomotorDose–response relationshipThreshold doseNeuromuscular AgentsAnesthesiaFemaleNeurology (clinical)medicine.symptombusinessBotulinum toxin typemedicine.drugFollow-Up StudiesAutonomic neuroscience : basicclinical
researchProduct

Chemically and electrically induced sweating and flare reaction

2004

Both thin afferent (nociceptors) and efferent (sympathetic sudomotor) nerve fibers can be activated electrically and chemically, resulting in neurogenic erythema and sweating. These reactions have been used before to assess the impairment of sympathetic and nociceptor fibers in humans. In this study, electrically induced sweating and erythema were assessed simultaneously in the foot dorsum and thigh, and were compared to chemically induced activation. Reproducible intensity-response relations (stimulation intensities 0-30 mA, 1 Hz) were obtained from 32 subjects. The steepest increase of the sweat response was induced at lower intensities as compared to that of the erythema (18.3 mA vs. 25.…

AdultMalemedicine.medical_specialtyErythemaEfferentSweatingStimulationFunctional LateralityCellular and Molecular NeuroscienceSex FactorsInternal medicineReflexLaser-Doppler FlowmetrymedicineHumansAgedSkinAnalysis of VarianceNeurogenic inflammationintegumentary systemFootEndocrine and Autonomic SystemsChemistryAge FactorsReproducibility of ResultsDose-Response Relationship RadiationMiddle AgedAcetylcholineElectric StimulationStimulation ChemicalSudomotorAutonomic nervous systemEndocrinologyThighErythemaAnesthesiaNociceptorFemaleNeurology (clinical)medicine.symptomAcetylcholinemedicine.drugAutonomic Neuroscience
researchProduct

Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.

2003

Botulinum toxin A (BoNT/A) has been used therapeutically to treat muscular hypercontractions and sudomotor hyperactivity. There is increasing evidence that BoNT/A might also have analgesic properties, in particular in headache. In the present investigation we tested the often cited hypothesis that BoNT/A-induced analgesia can be attributed to inhibition of neuropeptide release from nociceptive nerve fibers. In 15 healthy volunteers BoNT/A (5, 10, 20 mouse units BOTOX) or saline (contralateral side) was injected intracutaneously on the volar forearm. On day zero, the day of injection, no further tests were performed. We repeatedly elicited pain, mechanical hyperalgesia and neurogenic flare b…

AdultMalemedicine.medical_specialtyNeurologyAnalgesicNeuropeptidePainStimulationNerve FibersPsychophysicsMedicineHumansBotulinum Toxins Type APain MeasurementSkinHypohidrosisNeurogenic inflammationbusiness.industryNociceptorsAxonsElectric StimulationSudomotorNociceptionNeurologyHyperalgesiaAnesthesiaHyperalgesiaFemaleNeurology (clinical)medicine.symptomNeurogenic InflammationbusinessJournal of neurology
researchProduct

Sudomotor testing predicts the presence of neutralizing botulinum A toxin antibodies.

2002

The increasing number of patients being treated with botulinum toxin A complex (BoNT/A) has led to a higher incidence of neutralizing anti-BoNT/A antibodies (ABAs). Because BoNT/A is known to inhibit sweating, here we report sudometry as a possibility for predicting the presence of ABA. Sixteen patients suffering from spasmodic torticollis were selected: in 2 patients, BoNT/A treatment continued to be effective, in 9 patients, the treatment effect was impaired, and in 5 patients, secondary treatment failure developed. BoNT/A (100 mouse units, Dysport; Ipsen Pharma, Berkshire, United Kingdom) was injected subcutaneously into the lateral calves. Sweating was visualized with iodine starch stai…

AdultMalemedicine.medical_specialtySpasmodic TorticollisSweatingIn Vitro Techniquesmedicine.disease_causeGastroenterologyStatistics NonparametricCentral nervous system diseaseMicePredictive Value of TestsInternal medicinemedicineAnimalsHumansBotulinum Toxins Type ATorticollisAgedHypohidrosisbiologyToxinbusiness.industryMiddle Agedmedicine.diseaseAntibodies BacterialSudomotorNeurologyImmunologybiology.proteinClostridium botulinumAxon reflexFemaleNeurology (clinical)AntibodybusinessTorticollisAnnals of neurology
researchProduct

Comparison of the sympathetic skin response and continuous wave Doppler sonography of the radial artery.

1999

The value of neurophysiological tests of the autonomic nerve system is limited. One of the clinically most commonly applied test is the skin sudomotor response, frequently referred to as 'sympathetic skin response' (SSR). However, the SSR is a more qualitative than quantitative evaluation technique. Continuous wave (cw) Doppler sonography of the radial artery may be an alternative quantitative approach. We studied 41 age matched volunteers (23 female, 18 male; 16-82 years (mean age 53 years)). The stimulus was a loud and unexpected acoustic signal, alternatively a cough. SSR evaluation included the latency of onset, the duration and the amplitude of the response. Doppler evaluation also inc…

AdultMalemedicine.medical_specialtySympathetic nervous systemSympathetic Nervous SystemAdolescentPhysiologyDiastolesymbols.namesakemedicine.arteryInternal medicinemedicineHumansRadial arteryAgedSkinAged 80 and overAutonomic nervebusiness.industryGeneral NeuroscienceUltrasoundfood and beveragesUltrasonography DopplerMiddle AgedSurgerySudomotorAmplitudemedicine.anatomical_structureAcoustic StimulationRegional Blood FlowRadial ArterysymbolsCardiologyFemaleVascular ResistanceNeurology (clinical)businessDoppler effectAlgorithmsJournal of the autonomic nervous system
researchProduct

Ceftolozane Pharmacokinetics in a Septic Critically Ill Patient under Different Extracorporeal Replacement Therapies

2019

Ceftolozane-tazobactam (C/T), a novel fifth-generation cephalosporin/β-lactamase inhibitor combination active against multidrug-resistant (MDR) Pseudomonas aeruginosa, is currently approved by the U.S. Food and Drug Administration (FDA) to treat complicated intra-abdominal and urinary tract

Adultmedicine.medical_specialtymedicine.drug_classCritical IllnessUrinary systemCephalosporinHemodiafiltrationMicrobial Sensitivity TestsOff-label usemedicine.disease_causeExtracorporealPharmacokineticspolycyclic compoundsmedicineHumansPseudomonas InfectionsPharmacology (medical)Intensive care medicineLetter to the EditorPharmacologyCritically illbusiness.industryPseudomonas aeruginosaPrecursor Cell Lymphoblastic Leukemia-Lymphomabacterial infections and mycosesAnti-Bacterial AgentsCephalosporinsInfectious DiseasesPseudomonas aeruginosaFemaleCeftolozanebusinessAntimicrobial Agents and Chemotherapy
researchProduct